About
Rubitection’s assessment and management system provides a data-driven decision support platform for chronic wounds and dermatological conditions solving a $26 billion healthcare problem. A low risk FDA path way allows a quick path to a $4.2 billion US market. Sales and distribution partnerships enable $240 million in sales within 6 years of product launch within the wound care market.
Founders Bio
Dr. Sanna Gaspard is the CEO of Rubitection. She has a PhD in biomedical engineering with a specialization in medical device commercialization with experience in business strategy, IP strategy, and tech development.
Dr. Yannick Heintz is the data scientist who develops and optimizes the RAS algorithms. He has a PhD in chemical engineering with a specialization in system modeling.
Product Overview
Honors and Awards
- CTIP Flex Grant 2022 - grant awarded to support technology development
- Accenture Black Innovation 2021 - program to connect with Accenture's network
- Project W Tech Equity Hub 2022 - selected for showcase to women-focused NY Investors
- DOD Tech Connect Medical Innovation 2022 - invited to pitch to the Department of Defense to explore collaboration opportunities
- TechCrunch Startup Battlefield 200 - 2022
- IEEE Remote Patient Monitoring Innovation - 2022
- Competition - 1st place winner for home care application
- 2021 Lightship Capital Innovation Pitch Winner
- 2021 Consortium of Technology and Innovation in 10) Pediatrics (CTIP) Innovation Award
- Culture Shift's Labs Women in Health and Wellness
- 2021 Berkeley Ready Set Health Winner
- 2021 Optics & Photonics Top Entrepreneurs to Watch